BIOS Capital Management, LP
Source: SEC Form 13F · as of Mar 2026BIOS Capital Management, LP holds 5 biotech & pharma companies tracked by BioSniper, totaling $25.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$25.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Opus Genetics, Inc. (IRD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| IRDOpus Genetics, Inc. | 3,683,429 | $16.8M |
| CGTXCOGNITION THERAPEUTICS INC | 6,000,000 | $4.6M |
| RNTXRein Therapeutics, Inc. | 1,982,375 | $2.6M |
| LTRNLantern Pharma Inc. | 864,435 | $1.2M |
| INABIN8BIO, INC. | 167,805 | $248K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.